Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BCPS Exam > Critical Care: Pain and Agitation > Flashcards

Critical Care: Pain and Agitation Flashcards

1
Q

List 6 nonpharm strategies to improve patient comfort

A
  1. lighting
  2. music
  3. massage
  4. verbal reassurance
  5. avoidance of sleep deprivation
  6. patient positioning based on patient preferences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What two scales are preferred to measure pain in critical care patients who cannot communicate?

A
  1. Behavioral Pain scale (BPS)

3. Critical-Care Pain Observation Tool (CPOT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The total BPS score can range from ___ (no pain) to ___ (maximum pain). A score of _ or higher is generally considered to reflect unacceptable pain.

A
  1. No pain: 3
  2. Maximum pain: 12
  3. Unacceptable pain: 6
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The total CPOT score can range from __ to ___. A score of __ or higher is generally considered to reflect unacceptable pain.

A
  1. 0 to 8

2. A score of 3 or higher is generally considered to reflect unacceptable pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In patients who are receiving neuromuscular blockade, _____ indicate further assessment of pain is necessary

A

Vital signs (elevated HR or BP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What two scales are preferred to measure sedation?

A
  1. Richmond agitation-sedation scale (RASS)

2. Sedation-Agitation Scale (SAS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Goal sedation scores should be _____, but generally a SAS score of ___ or a RASS score of ___ is recommended

A
  1. Scores should be individualized for each patient
  2. SAS: 3-4 (sedated - calm and cooperative)
  3. RASS of 0 to -1 (alert and calm - drowsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe analgosedation in treatment of agitation

A
  1. Pain and discomfort are primary causes of agitation

2. Treat pain first and add a sedative if needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

To minimize discomfort, use ____ and _____ before potentially painful procedures

A
  1. Bolus dose analgesics

2. Nonpharmacologic interventions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In critical care, _____ are considered first line for the treatment of nonneuropathic pain.

A

Opioids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In critical care, ____ and ____ are considered first line for neuropathic pain

A
  1. Gabapentin

2. Carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe multimodal analgesia

A
  1. Nonopioid analgesics (e.g. acetaminophen, ketamine) can be used in cojunction with opioids
  2. To optimize pain control and to avoid dose-related adverse effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NSAIDs are usually avoided in critical care because of the risk of ______ and _____

A
  1. Risk of bleeding

2. Kidney injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In mechanically ventiled patients, which type of sedative is preferred to improve clinical outcomes?

A

Nonbenzodiazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the relationship between targeting light sedation and improving patient outcomes?

A
  1. Light sedation is needed for evaluating pain and delirium

2. and for early patient mobility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How should analgesics and sedative dosing be guided?

A

To achieve pain and sedation goals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

List three dosing strategies for analgosedation

A
  1. As needed
  2. Intermittent dosing
  3. Bolus dose with continuous infusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

In a patient receiving a continuous infusion plus bolus strategy, what is the preferred strategy for alleviating pain or agitation? Why?

A
  1. Increase bolus dose before or instead of increasing the infusion rate
  2. Bolus has a faster onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What two drugs are exceptions to bolus dosing strategies?

A

Propofol and dexmedetomidine which can cause hypotension and bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Use bolus dosing ____, such as before dressing changes

A

Proactively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

List six potential benefits of schedule daily awakening

A
  1. Assess the patient’s neurologic function
  2. reevaluate lowest effective opioid or sedative dose
  3. Prevent drug accumulation and overdose
  4. Reduce time on ventilator (mixed evidence)
  5. Reduce mortality and ICU length of stay when combined with a spontaneous breathing trial
  6. Reduce symptoms of PTSD and post-ICU syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is scheduled daily awakening performed in the ICU?

A
  1. Interruption of continuous infusion opioid/sedatives
  2. Until patient is awake (SAS of 4 or RASS of 0)
  3. If the patient becomes agitated/discomfort/pain (e.g. SAS or 5 or RASS of 1), reinitiate, ideally at a reduced dose.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

List three common opioid analgesics used in critical care

A
  1. morphine
  2. fentanyl
  3. hydromorphoen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Rank the onset of Morphine, Fentanyl, and Hydromorphone, and state the minutes

A
  1. Fentanyl (1-2 minutes)
  2. Morphine (5-10 minutes)
  3. Hydromorphone (5-15 minutes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Rank the duration of Morphine, Fentanyl, and Hydromorphone, and state the hours
1. Fentanyl (1-5 hours) 2. Morphine (2-4 hours) 3. Hydromorphone (2-6 hours)
26
Rank the half-life of Morphine, Fentanyl, and Hydromorphone, and state the hours
1. Hydromorphone (2-3 hours) 2. Fenatnyl (2-4 hours) 3. Morphine (3-4 hours)
27
For each Morphine, Fentanyl, and Hydromorphone, are they prolonged in renal failure?
1. Morphine: Yes 2. Fentanyl: No 3. Hydromorphone: No
28
Morphine, Fentanyl, and Hydromorphone, are they prolonged in hepatic failure?
1. Morphine: Yes 2. Fenatnyl: yes 3. Hydromorphone: yes
29
Morphine, Fentanyl, and Hydromorphone, do they have active metabolites?
1. Morphine: Yes 2. Fentanyl: No 3. Hydromorphone: No
30
List four critical care adverse effects of opioids (not all)
1. Hypotension 2. Flushing 3. Bronchospasm 4. Constipation
31
Morphine, Fentanyl, and Hydromorphone, do they cause hypotension?
1. Morphine: Yes 2. Fentanyl: No 2. Hydromorphone: Yes
32
Morphine, Fentanyl, and Hydromorphone, do they cause flushing?
1. Morphine: Yes 2. Fentanyl: No 3. Hydromorphone: Yes
33
Morphine, Fentanyl, and Hydromorphone, do they cause bronchospasm?
1. Morphine: Yes 2. Fentanyl: no 3. Bronchospasm: no
34
Morphine, Fentanyl, and Hydromorphone, do they cause constipation?
1. Morphine: Yes 2. Fentanyl: Yes 3. Hydromorphone: Yes
35
What CC adverse effects does morphine cause?
1. Hypotension 2. Flushing 3. Bronchospasm 4. Constipation
36
What CC adverse effects does fentanyl cause?
1. Constipation
37
WHat CC adverse effects does hydromorphine cause?
1. Hypotension 2. Flushing 3. Constipation ((NOT bronchospasm))
38
List three possible critical care adverse outcomes of benzodiazepines
1. Prolonged duration of mechanical ventilation 2. Increased ICU length of stay 3. Development of delirium
39
List three non-benzo sedatives
1. Propofol 2. Dexmedetomidine 3. Ketamine
40
List three common CC benzodiazepines
1. diazepam 2. lorazepam 3. midazolam
41
Diazepam, lorazepam, midazolam, rank the onset and state minutes
1. Midazolam = diazepam (2-5 minutes) | 3. Lorazepam (15-20 minutes)
42
Diazepam, lorazepam, midazolam, rank the duration of effect (hours)
1. Midazolam (1-2 hours) 2. Diazepam (2-4 hours) 3. Lorazepam (4-6 hours)
43
Diazepam, lorazepam, midazolam, rank the elimination half-life
1. Midazolam (1-10 hours) 2. Lorazepam (10-20 hours) 3. Diazepam (24-120 hours)
44
Diazepam, lorazepam, midazolam, do they have active metabolites?
1. Diazepam: Yes 2. Lorazepam: No 3. Midazolam: Yes
45
Diazepam, lorazepam, midazolam, prolonged in renal failure?
1. Diazepam: Yes 2. Lorazepam: No 3. Midazolam: Yes
46
Diazepam, lorazepam, midazolam, prolonged in hepatic failure?
1. Diazepam: Yes 2. Lorazepam: No 3. Midazolam: Yes
47
Diazepam, lorazepam, midazolam, CYP3A4 interactions?
1. diazepam: Yes 2. Lorazepam: No 3. Midazolam: Yes
48
List three important critical care adverse effects of benzodiazepines (not all)
1. Hypotension 2. Thrombophlebitis 3. Propylene glycol toxicity
49
Diazepam, lorazepam, midazolam, cause hypotension?
1. Diazepam: Yes 2. Lorazepam: No 3. Midazolam: No
50
Diazepam, lorazepam, midazolam, cause thrombophlebitis?
1. Diazepam: Yes 2. Lorazepam: Maybe 3. Midazolam: No
51
Diazepam, lorazepam, midazolam, cause propylgene glycol toxicity?
1. Diazepam: No 2. Thrombophlebitis: Yes 3. Midazolam: No
52
Describe intermittent dosing of lorazepam
1. Lorazepam 1-4 mg every 2-6 hours
53
Describe continuous infusion of lorazepam
1. Start at 1 mg/hour and titrate to goal (e.g. RASS, SAS) | 2. Total daily doses as low as 1 mg/kg can cause propylene glylcol toxicity
54
How to monitor for propylene glycol toxicity with lorazepam?
1. Osmolal gap greater than 10-12 mOsm/L
55
Describe midazolam intermittent dosing
1-4 mg every 15 minutes to 1 hour
56
Describe midazolam continuous infusion
Start at 1 mg/hour and titrate to goal
57
Prolonged infusions of midazolam may accumulate because of its ___ and ___, especially in patients with _____
1. Greater lipophilicity 2. Active metabolites 3. Especially in patients with renal dysfunction
58
What is the preferred BZD in severe hepatic dysfunction?
Lorazepam
59
What is a useful role for midazolam? Why?
1. Procedural sedation 2. Dressing changes 3. Rapid onset and short duration
60
Propofol is more commonly used than BZD because of its _____, ___ and ____
1. Shorter duration 2. Easy titration 3. Predictability
61
In general, propofol is used in ___ because of its risk of ______
1. Intubated patients | 2. Respiratory depression
62
Describe results of MIDEX study
1. Dexmedetomidine is noninferior to midazolam in maintaining light to moderate sedation 2. Dex reduced the duration of mechancial ventilation compared with midazolam
63
Describe results of PRODEX
1. Dexmedetomidine is noninferior to propofol in maintaining light to moderate sedation 2. Dex was noninferior compared to propofol in duration of mechanical ventilation
64
Describe onset and duration of propofol
1. Onset: 1-2 minutes | 2. Duration: 3-5 minutes
65
Why are loading doses avoided with propofol?
Risk of hypotension
66
Describe monitoring for propofol
1. BP 2. Triglycerides 3. Adjust lipids/calories provided by nutrition support (1.1 kcal/mL) 4. Propofol-related infusion syndrome
67
List seven symptoms of propofol-related infusion syndrome
1. Metabolic acidosis 2. Cardiac failure 3. Arrhythmias (e.g. bradycardia) 4. Cardiac arrest 5. Rhabdomyolysis 6. Hyperkalemia 7. Kidney failure
68
What types of infusions of propofol pose greatest risk for propofol-related infusion syndrome
greater than 50 mcg/kg/minute, prolonged infusions
69
Describe dosing of propofol
1. Initiate at 5 mcg/kg/minute 2. Titrate to acehive sedation goals 3. Increment by 5 mcg/kg/minute every 5 minutes 4. avoid greater than 50 mcg/kg/minute
70
Describe respiratory depression risk of dexmedetomidine
No risk of respiratory depression
71
Describe onset and duration of dexmedetomidine
1. Onset: 5-15 miutes if bolus 2. duration: (2 hour half life) 3. Longer duration in patients with severe hepatic dysfunction
72
When is a loading dose of dexmedetomidine used? WHen is it avoided and why?
1. Loading dose is suggested in patients underoing surgery | 2. It is not recommended for patients in the ICU because of bradycardia and hypotension.
73
Describe monitoring of dexmedetomidine
Bradycardia, hypotension
74
Describe dosing of dexmedetomidine
1. Maintenace dose of 0.2 mcg/kg/hour is approved for a maximum of 24 hours. 2. There is evidence showing safety and efficacy at doses up to 1.5 mcg/kg/hour, which is most commonly used.
75
withdrawal symptoms from dexmedetomidine (e.g. ________, ____, ___) have occurred after prolonged use (what tiem period?)
1. Nausea 2. Vomiting 3. Agitation 4. 1 week
76
Describe risk of respiratory depression with ketamine
No risk of respiratory depression
77
Describe major adverse effects of ketamine
1. Hypertension 2. tachycardia 3. Delirium
78
Describe the risk of delirium with ketamine
There is a risk of emergence delirium when high doses are tapered off

BCPS Exam (34 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions